NCT05020184View on ClinicalTrials.gov

Effect of Oral Cimetidine in the Protoporphyrias

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

April 24, 2025

Study Completion Date

April 24, 2025

Conditions
Erythropoietic ProtoporphyriaX-linked Protoporphyria
Interventions
DRUG

Cimetidine

Oral Cimetidine 800mg twice daily.

DRUG

Placebo

Placebo twice daily

Trial Locations (3)

27157

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem

77555

University of Texas Medical Branch, Galveston

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Wake Forest University Health Sciences

OTHER

collaborator

The University of Texas Medical Branch, Galveston

OTHER

lead

Amy K. Dickey, M.D.

OTHER